Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Couselo EM"'
Autor:
Amaral T; Skin Cancer Clinical trials Center - University of Tuebingen, Tuebingen, Germany., Ottaviano M; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione 'G. Pascale', Napoli, Italy., Arance A; Department of Medical Oncology and IDIBAPS, Hospital Clinic y Provincial de Barcelona, Barcelona, Spain., Blank C; Department of Medical Oncology and Division of Immunology, The Netherlands Cancer Institute Antoni van Leeuwenhoek Ziekenhuis (NKI), Amsterdam; Leiden University Medical Center (LUMC), Leiden, The Netherlands; University Clinic Regensburg, Regensburg, Germany., Chiarion-Sileni V; Department of Oncology, Melanoma Unit, Istituto Oncologico Veneto, IOV - IRCCS, Padova, Italy., Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital Herlev and Gentofte, Herlev, Denmark., Dummer R; Department of Dermatology, Skin Cancer Center, USZ - University Hospital Zürich, University of Zurich, Zürich, Switzerland., Garbe C; Department of Dermatology, Center for DermatoOncology, University Hospital Tuebingen, Tuebingen, Germany., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center and The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, USA., Gogas H; First Department of Medicine, School of Medicine, National and Kapodistrian University of Athens - School of Medicine, Athens, Greece., Guckenberger M; Department of Radiation Oncology, University Hospital Zürich, University of Zürich, Zürich, Switzerland., Haanen J; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands; Oncology Service, Melanoma Clinic, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Hamid O; Medical Oncology, Cutaneous Malignancies, The Angeles Clinic and Research Institute, A Cedars Sinai Affiliate - Los Angeles, USA., Hauschild A; Department of Dermatology, UKSH - Universitätsklinikum Schleswig-Holstein - Campus Kiel, Kiel, Germany., Höller C; Department of Dermatology, Medical University of Vienna, Vienna, Austria., Lebbé C; Université Paris Cite, AP-HP Dermato-oncology and CIC, Cancer institute APHP, Nord Paris Cité, INSERM U976, Saint Louis Hospital, Paris, France., Lee RJ; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK., Long GV; Melanoma Institute Australia, The University of Sydney, Sydney; Department Medical Oncology, Royal North Shore Hospital, Sydney; Mater Hospital, Sydney, Australia., Lorigan P; Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester; Faculty of Biology Medicine and Health, The University of Manchester, Manchester, UK., Couselo EM; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Nathan P; Mount Vernon Cancer Centre, Northwood, UK., Robert C; Department of Oncology, Institut Gustave Roussy and Paris-Saclay University, Villejuif., Romano E; Department of Oncology, Center for Cancer Immunotherapy, Institut Curie, Paris, France., Schadendorf D; Department of Dermatology, WTZ - Westdeutsches Tumorzentrum Essen, National Center for Tumor Diseases (NCT-West), Campus Essen, Essen; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany., Sondak V; Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, USA., Suijkerbuijk KPM; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands., van Akkooi ACJ; Melanoma Institute Australia, The University of Sydney, Sydney; Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, Australia., Michelin O; Department of Oncology, Geneva University Hospital, Geneva, Switzerland., Ascierto PA; Melanoma, Cancer Immunotherapy and Development Therapeutics Unit, Instituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Nov 13. Date of Electronic Publication: 2024 Nov 13.
Autor:
Gogas H; National and Kapodistrian University of Athens, Athens, Greece. helgogas@gmail.com., Ravimohan S; Bristol Myers Squibb, Princeton, NJ, USA., Datta A; Bristol Myers Squibb, Princeton, NJ, USA., Chhibber A; Bristol Myers Squibb, Princeton, NJ, USA., Couselo EM; Vall d'Hebron Barcelona Hospital and Vall d'Hebron Instituto de Oncología (VHIO), Barcelona, Spain., Diab A; MD Anderson Cancer Center, Houston, TX, USA., Pereira C; Fundação Pio XII - Hospital de Câncer de Barretos, São Paulo, Brazil., Quéreux G; Unité Cancéro-Dermatologie, Nantes, France., Sandhu S; Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Curti B; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Khushalani NI; Moffitt Cancer Center, Tampa, FL, USA., Taylor MH; Eerle A. Chiles Research Institute, Providence Cancer Institute of Oregon, Portland, OR, USA., Daniels GA; Moores UCSD Cancer Center, La Jolla, CA, USA., Spreafico A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Meniawy T; Department of Medical Oncology, Sir Charles Gairdner Hospital, Nedlands, Australia., Van Den Eertwegh AJM; Department of Medical Oncology, Amsterdam UMC, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, the Netherlands., Sun Y; Bristol Myers Squibb, Princeton, NJ, USA., Arriaga Y; Bristol Myers Squibb, Princeton, NJ, USA., Zhou M; Bristol Myers Squibb, Princeton, NJ, USA., Long GV; The Melanoma Institute Australia, The University of Sydney and Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Lebbé C; Université Paris Cité, Dermato-Oncology and CIC AP-HP Hôpital Saint Louis, Cancer Institute APHP, Nord-Université Paris Cité, Paris, France.; INSERM U976 HIPI, Paris, France.
Publikováno v:
NPJ precision oncology [NPJ Precis Oncol] 2024 Jul 19; Vol. 8 (1), pp. 150. Date of Electronic Publication: 2024 Jul 19.
Autor:
Spreafico A; Department of Medicine, Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, University Health Network and University of Toronto, Toronto, ON, Canada., Couselo EM; Department of Medical Oncology, Vall d'Hebron University Hospital and Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Irmisch A; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Bessa J; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Au-Yeung G; Department of Medical Oncology, Peter MacCallum Cancer Center and Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, VIC, Australia., Bechter O; Department of General Medical Oncology, Universitair Ziekenhuis (UZ), Leuven, Leuven, Belgium., Svane IM; National Center for Cancer Immune Therapy and Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Sanmamed MF; Department of Medical Oncology, Clínica Universidad de Navarra and Immunology and Immunotherapy Program, Center for Applied Medical Research (CIMA), Pamplona, Spain.; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Gambardella V; Centro de Investigación Biomédica en Red Cáncer (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain.; Department of Medical Oncology, Hospital Clínico Universitario de Valencia, INCLIVA Biomedical Research Institute, University of Valencia, Valencia, Spain., McKean M; Sarah Cannon Research Institute at Tennessee Oncology, Nashville, TN, United States., Callahan M; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, United States., Dummer R; Department of Dermatology, University Hospital Zurich and University of Zurich, Zurich, Switzerland., Klein C; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Umaña P; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Justies N; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Heil F; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Fahrni L; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Opolka-Hoffmann E; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Waldhauer I; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Bleul C; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland., Staack RF; Roche Pharma Research & Early Development, Roche Innovation Center Munich, Penzberg, Germany., Karanikas V; Roche Pharma Research & Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Fowler S; Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Mar 21; Vol. 14, pp. 1346502. Date of Electronic Publication: 2024 Mar 21 (Print Publication: 2024).
Autor:
Mandalà M; Unit of Medical Oncology, University of Perugia, Perugia, Italy. Electronic address: mario.mandala@unipg.it., Lorigan P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Sergi MC; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Benannoune N; Gustave Roussy Cancer Campus, Villejuif, France., Serra P; The University of Manchester, Oxford Rd, Manchester M13 9PL, UK., Vitale MG; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy., Giannarelli D; Epidemiology and Biostatistics, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Arance AM; Hospital Clínic Barcelona, 08036 Barcelona, Spain., Couselo EM; Department of Medical Oncology. Vall d'Hebron Hospital, Barcelona, Spain & Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Neyns B; Department of Medical Oncology, UZ Brussel, Brussels, Belgium., Tucci M; Medical Oncology Unit, Azienda Ospedaliero Universitaria Policlinico di Bari, Bari, Italy., Guida M; Rare Tumors and Melanoma Unit, IRCCS Istituto dei Tumori 'Giovanni Paolo II,' Bari, Italy., Spagnolo F; IRCCS Ospedale Policlinico San Martino, Skin Cancer Unit, Genova, Italy., Rossi E; Medical Oncology, Fondazione Policlinico Universitario, A. Gemelli IRCCS, Rome, Italy., Occelli M; Medical Oncology, AO S.Croce e Carle, Cuneo, Italy., Queirolo P; IEO European Institute of Oncology, IRCCS, Milan, Italy., Quaglino P; Department of Dermatology, University of Turin, Turin, Italy., Depenni R; University of Modena and Reggio Emilia, Department of Oncology, Hematology, Modena, Emilia-Romagna, Italy., Merelli B; Oncology Unit, ASST Papa Giovanni XXIII, Bergamo, Italy., Placzke J; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Di Giacomo AM; Center for Immuno-Oncology, University Hospital of Siena, Siena, Italy., Del Vecchio M; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Indini A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., da Silva IP; Melanoma Institute Australia, University of Sydney, and Blacktown Hospital, Sydney, New South Wales, Australia., Menzies AM; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Long GV; Melanoma Institute Australia, University of Sydney, and Royal North Shore and Mater Hospitals, Sydney, New South Wales, Australia., Robert C; Gustave Roussy and Paris-Saclay University, Villejuif, France., Rutkowski P; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Ascierto PA; Department of Melanoma, Cancer Immunotherapy and Development Therapeutics, I.N.T. IRCCS Fondazione 'G. Pascale' Napoli, Naples, Italy.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Mar; Vol. 199, pp. 113542. Date of Electronic Publication: 2024 Jan 19.
Autor:
Weiss SA; Yale University School of Medicine, New Haven, Connecticut., Sznol M; Yale University School of Medicine, New Haven, Connecticut., Shaheen M; University of Arizona Cancer Center, Tucson, Arizona., Berciano-Guerrero MÁ; Medical Oncology Intercenter Unit, Regional and Virgen de la Victoria University Hospitals, Instituto de Investigación Biomédica de Málaga y Plataforma en Nanomedicina-IBIMA Plataforma BIONAND, Málaga, Spain., Couselo EM; Vall d'Hebron University Hospital, Barcelona, Spain., Rodríguez-Abreu D; Universidad de Las Palmas de Gran Canaria, Las Palmas, Spain., Boni V; START Madrid-CIOCC, Hospital Universitario HM Sanchinarro, Madrid, Spain., Schuchter LM; Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Gonzalez-Cao M; Instituto Oncológico, Quirón Dexeus University Hospital, Barcelona, Spain., Arance A; Hospital Clínic Barcelona, Barcelona, Spain., Wei W; Yale University School of Medicine, New Haven, Connecticut., Ganti AK; VA Nebraska Western Iowa Healthcare System and University of Nebraska Medical Center, Omaha, Nebraska., Hauke RJ; Nebraska Cancer Specialists, Omaha, Nebraska., Berrocal A; University General Hospital of Valencia, Valencia, Spain., Iannotti NO; Hematology Oncology Associates of the Treasure Coast, Port Saint Lucie, Florida., Hsu FJ; Apexigen America, Inc., San Carlos, California., Kluger HM; Yale University School of Medicine, New Haven, Connecticut.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Jan 05; Vol. 30 (1), pp. 74-81.
Autor:
Mohr P; Department of Dermatology, Elbe Kliniken, Stade, Germany., Kiecker F; Department of Dermatology and Allergy, Skin Cancer Center, Charité Universitätsmedizin Berlin, Berlin, Germany., Soriano V; Department of Medical Oncology, Fundación Instituto Valenciano de Oncología, Valencia, Spain., Dereure O; Department of Dermatology and INSERM U1058 'pathogenesis and control of chronic infections', University of Montpellier, Montpellier, France., Mujika K; Department of Medical Oncology, Onkologikoa-Oncology Institute Gipuzkoa, Gipuzkoa, Spain., Saiag P; Department of General and Oncologic Dermatology Ambroise Paré Hospital, APHP; EA 4340 'Biomarkers in cancerology and hemato-oncology', UVSQ, Université Paris-Saclay, Boulogne-Billancourt, France., Utikal J; Skin Cancer Unit, German Cancer Research Center (DKFZ), Heidelberg, Germany and Department of Dermatology, Venereology and Allergology; University Medical Center, Ruprecht-Karl University of Heidelberg, Mannheim, Germany., Koneru R; RS McLaughlin Durham Regional Cancer Centre, Lakeridge Health, Oshawa, Oshawa, Ontario, Canada., Robert C; Dermatology Unit, Gustave Roussy and Paris-Saclay University, Villejuif, France., Cuadros F; Medical Oncology, Instituto de Oncologia de Rosario, Rosario, Santa Fe, Argentina., Chacón M; Departments of Medical and Surgical Oncology, Instituto Alexander Fleming, Buenos Aires, Argentina., Villarroel RU; Cancer Institute São Vicente de Paulo, Passo Fundo, RS, Brazil., Najjar YG; UPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA 15213, USA., Kottschade L; Department of Medical Oncology, Mayo Clinic, Rochester, MN 55905, USA., Couselo EM; Department of Medical Oncology, Vall d'Hebron Hospital and VHIO (Vall d'Hebron Institute of Oncology), Barcelona, Spain., Koruth R; Novartis Pharmaceuticals Corporation, East Hanover, NJ 07936, USA., Guérin A; Analysis Group, Inc. Montreal, Quebec, Canada., Burne R; Analysis Group, Inc. Montreal, Quebec, Canada., Ionescu-Ittu R; Analysis Group, Inc. Montreal, Quebec, Canada., Perrinjaquet M; Navigant Germany GmbH, Berlin, Germany., Zager JS; Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center, Tampa, FL 33612, USA.
Publikováno v:
Melanoma management [Melanoma Manag] 2019 Oct 04; Vol. 6 (4), pp. MMT33. Date of Electronic Publication: 2019 Oct 04.